Schnieders Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Schnieders Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$301K	Hold	601	–	–	0.04%	196
2026 Q1	$295K	Sell	601 -171	-22%	-$92.8K	0.05%	169
2025 Q4	$447K	Sell	772 -35	-4%	-$19.8K	0.07%	142
2025 Q3	$391K	Buy	807 +129	+19%	+$60K	0.07%	155
2025 Q2	$275K	Sell	678 -37	-5%	-$15.5K	0.05%	190
2025 Q1	$356K	Hold	715	–	–	0.08%	148
2024 Q4	$372K	Buy	715 +5	+0.7%	+$2.75K	0.07%	147
2024 Q3	$439K	Buy	710 +70	+11%	+$41.4K	0.08%	141
2024 Q2	$354K	Hold	640	–	–	0.07%	147
2024 Q1	$372K	Sell	640 -139	-18%	-$78K	0.08%	144
2023 Q4	$413K	Hold	779	–	–	0.09%	130
2023 Q3	$394K	Hold	779	–	–	0.09%	129
2023 Q2	$406K	Hold	779	–	–	0.08%	136
2023 Q1	$449K	Hold	779	–	–	0.1%	131
2022 Q4	$429K	Hold	779	–	–	0.1%	129
2022 Q3	$395K	Hold	779	–	–	0.1%	129
2022 Q2	$423K	Buy	779 +285	+58%	+$157K	0.13%	120
2022 Q1	$292K	Buy	494 +107	+28%	+$61.5K	0.07%	164
2021 Q4	$258K	Hold	387	–	–	0.06%	171
2021 Q3	$221K	Buy	+387	New	+$212K	0.06%	179

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Schnieders Capital Management's TMO Position: Q2 2026 in Review

Schnieders Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 601 shares worth $301K. The position accounts for 0.04% of the portfolio, ranked #196.

Schnieders Capital Management first reported a position in TMO in Q3 2021 and has held it in 20 quarters since. The position peaked at $449K in Q1 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Schnieders Capital Management held 601 shares of Thermo Fisher Scientific worth $301K as of Q2 2026.
Schnieders Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.04% of Schnieders Capital Management's portfolio in Q2 2026, its #196 holding.
Schnieders Capital Management first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 20 quarters since.
Schnieders Capital Management's Thermo Fisher Scientific position peaked at $449K in Q1 2023.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Schnieders Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.